INOVIS Intelligent Competitor Strategies  CONTACT US


PharmaCI USA

join INOVIS at more events +

INOVIS conference booth
look for our booth!

INOVIS presents ...

DEVELOPING YOUR COMPETITIVE EXPERTISE: Late Life-Cycle Management & Competitive Uncertainty +


Baljit Singh, INOVISDr. Baljit Singh
Managing Director & Partner, INOVIS
(formerly Director, Integrated Insights, Novartis)


Dr. Satish Kumar
Head, CI Strategies, Generics & Biosimilars, INOVIS
(formerly Sanofi-Genzyme)

Dr. Harshal Kubavat
Head, Strategic Consulting, Life Sciences, INOVIS
(formerly Brand Manager, Roche)

Late Life-Cycle Management & Competitive Uncertainty

Tuesday, September 17, 9:30 to 11:45 AM

This workshop session (with breakouts), will give participants first-hand insights from combined 30+ years of experience dealing with uncertainty and helping Big Pharma optimize their late-life cycle strategies — i.e. enabling companies to protect and optimize their assets.

PART-A: Threat-Analysis as a Strategy to Manage Uncertainty

Using an INOVIS proprietary strategy-gaming exercise, participants will be provided with a business case study and suggested frameworks to perform threat analysis, in order to:

PART-B: Gx/Biosimilar CI Assessments and Strategic Framework

Leveraging a specific Gx / biosimilar example, the second part of this workshop will address and highlight best practices when implementing follow-up activities related to identified actions during a strategic gaming exercise, this interactive workshop session will specifically enable you to:

FOR MORE INFO please contact Baljit Singh >

Can Our Industry Keep Up?

Thursday, September 19, 2:50 to 3:30 PM

By exploring the rapid evolutions taking place inside and outside of the pharmaceutical industry, we will consider whether our profession has adapted at a similar pace and what more can be done to elevate our role.

With seemingly endless "on-demand", "tailored", "agile" and "VUCA-driven" solutions touching our professional and personal lives every day, this session seeks to address what best practices, ideas and solutions can be leveraged into our working practices to generate further impact to our teams, stakeholders and wider organizations. Delivered by two leading CI industry experts, the INOVIS team looks forward to an engaging, dynamic and hopefully provocative audience participation-driven approach, which will leave you with a fresh outlook on the future of CI in the Pharmaceutical industry and how to optimize your personal impact on decision making!

FOR MORE INFO please contact Baljit Singh >

thank you for your interest in INOVIS Competitor Intelligence and Strategy